Regulatory Affairs in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Regulatory Affairs in Clinical Trials in Brazil

Regulatory Affairs in Clinical Trials in Brazil – Clinical Research LATAM

Clinical trials play a pivotal role in advancing medical knowledge and bringing new therapies to patients. However, conducting clinical trials requires adherence to rigorous regulatory frameworks, ensuring patient safety and data integrity. In Brazil, a country known for its vibrant healthcare ecosystem, regulatory affairs in clinical trials are governed by stringent guidelines and processes.

This blog post provides an in-depth exploration of regulatory affairs in clinical trials in Brazil, highlighting key considerations and challenges faced by sponsors, investigators, and regulatory authorities.

Regulatory Landscape in Brazil (approximately 150 words): Brazil’s regulatory framework for clinical trials is primarily overseen by the National Health Surveillance Agency (ANVISA) and the National Council for Ethics in Research (CONEP).

ANVISA serves as the main regulatory authority responsible for assessing and approving clinical trial applications, while CONEP focuses on ethical considerations. These regulatory bodies collaborate to ensure the safety, quality, and ethical conduct of clinical trials in Brazil.

The Approval Process

To initiate a clinical trial in Brazil, sponsors must obtain approval from ANVISA and CONEP. The process begins with the submission of a comprehensive dossier containing information on the investigational product, study protocol, and supporting documentation. ANVISA reviews the dossier to assess the safety, efficacy, and quality of the proposed trial.

The evaluation may involve a multidisciplinary analysis by experts in various scientific disciplines. Once ANVISA grants approval, the sponsor proceeds to seek ethical clearance from CONEP, which evaluates the study design and ethical considerations.

Regulatory Affairs in Clinical Trials in Brazil

Regulatory Affairs in Clinical Trials in Brazil

Regulatory Affairs in Clinical Trials in Brazil

Key Considerations and Challenges

Regulatory Compliance: Compliance with ANVISA’s regulations and guidelines is crucial to ensure the smooth progress of clinical trials in Brazil. It is essential to remain updated on the evolving regulatory landscape and adhere to good clinical practice (GCP) guidelines to maintain data integrity and patient safety.


Local Language and Cultural Factors: Brazil’s official language is Portuguese. Sponsors must ensure accurate translation of documents and effective communication with local stakeholders to overcome language barriers.

Cultural considerations should also be taken into account when designing study protocols, ensuring they are aligned with local healthcare practices and patient populations.


Timelines and Delays: The regulatory approval process in Brazil can be time-consuming, leading to potential delays in trial initiation. Sponsors should factor in these timelines when planning their clinical development programs and engage with regulatory authorities early in the process to facilitate efficient communication and minimize delays.


Ethical Review and Informed Consent: CONEP plays a critical role in ensuring ethical standards are met in clinical trials. Obtaining informed consent from participants is vital, emphasizing the importance of clear and culturally appropriate information. Sponsors must work closely with investigators to develop robust informed consent processes.


Pharmacovigilance and Safety Reporting: Sponsors are responsible for monitoring and reporting adverse events and ensuring pharmacovigilance throughout the trial. Compliance with ANVISA’s guidelines for safety reporting is essential to maintain patient safety and regulatory compliance.


Regulatory affairs in clinical trials in Brazil present unique challenges and considerations that require careful navigation. Sponsors, investigators, and regulatory authorities must collaborate to ensure compliance with regulatory requirements, while maintaining patient safety and data integrity.

By staying abreast of evolving regulations, engaging with local stakeholders, and planning for potential delays, sponsors can optimize the clinical trial process in Brazil and contribute to the advancement of medical knowledge and patient care.

Regulatory Affairs in Clinical Trials in Brazil 

Source: Duke Clinical Research Institute

Regulatory Affairs in Clinical Trials in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Regulatory Affairs in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Regulatory Affairs in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Regulatory Affairs in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Regulatory Affairs in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Regulatory Affairs in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Regulatory Affairs in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Regulatory Affairs in Clinical Trials in Brazil

The Cohortias Team

Regulatory Affairs in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Regulatory Affairs in Clinical Trials in Brazil

Network & Partnerships